The global neglected tropical disease treatment market size will grow by USD 2.13 billion during 2019-2023. The neglected tropical disease treatment market report provides a detailed analysis of the market by type (antiparasitic drugs, antibacterial drugs, and antiviral drugs) and geography (Asia, North America, and ROW). The report analyzes the market’s competitive landscape and offers information on several companies including Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Novartis AG, and Pfizer Inc.
Key Insights on Neglected Tropical Disease Treatment Market – Global Forecast 2019-2023
Browse ToC and LoE with selected illustrations and example pages from the market report
Industry Overview
The initiatives undertaken by several organizations across the world to increase awareness and access to medicines for neglected tropical diseases are expected to drive the neglected tropical disease treatment market growth. The increasing prevalence of neglected tropical diseases has created importance to raise awareness. For instance, the World Health Organization (WHO) has aimed at creating awareness on one of the most neglected tropical diseases, Buruli ulcer, through its initiative Global Buruli Ulcer. In January 2019, the United Nations Development Programme (UNDP) along with several other organizations has aimed to improve access of medicines, vaccines, and diagnostics for neglected tropical diseases through the initiative, Uniting Efforts for Innovation, Access, and Delivery. Many such initiatives are expected to increase the consumption of neglected tropical disease treatment drugs over the forecast period.
The lack of proper sanitation, unavailability of basic facilities such as clean water, and poor disease control measures are some of the root causes of neglected tropical diseases. Governments across the world are undertaking preventive measures to mitigate the spread of neglected tropical diseases. For instance, India’s Stop Dengue mission is aimed at reducing dengue-related mortality and morbidity in the country by motivating people to adopt better sanitation practices. Additionally, organizations such as WHO is helping the country to reduce the number of malaria cases by providing free bed nets. Such non-therapeutic approaches to address the root disease causes are expected to support the growth of the global neglected tropical disease treatment market size at a CAGR of almost 5% during 2019-2023.
Top Companies in Neglected Tropical Disease Treatment Market
The global neglected tropical disease treatment market is fairly concentrated. The research report provides a detailed analysis of the market’s competitive landscape and provides information on the products offered by various companies. Key insights provided by the market report will help companies create effective strategies to improve their revenue share.
The report offers a detailed analysis of several leading companies including:
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Novartis AG
- Pfizer Inc.
Market Segmentation
Neglected Tropical Disease Treatment Market by Type
- Antiparasitic drugs
- Antibacterial drugs
- Antiviral drugs
Antiparasitic drugs are most commonly used for the treatment of neglected tropical diseases. The availability, approval, and development of antiparasitic therapeutics to treat neglected tropical diseases have accelerated the growth. The high prevalence of parasite-infected diseases in remote and rural areas and in urban slums due to poor sanitation practices have increased the demand for antiparasitic drugs. There are several approved antiparasitic drugs in the market for the treatment of neglected tropical diseases and many market vendors are developing novel drugs. These factors are driving the growth of the segment.
Neglected Tropical Disease Treatment Market by Region
- Asia
- North America
- ROW
Neglected tropical disease treatment companies find a large number of growth opportunities outside Asia and North America. The increasing prevalence of neglected tropical diseases in some countries has led to increased mortality rates. The poor sanitation facilities in African countries has increased the prevalence of neglected tropical diseases that cause disfigurement and long-lasting disabilities. The region is also witnessing the launch of several programs to help reduce the prevalence of neglected tropical diseases. Many such factors will drive the growth of neglected tropical disease treatment market size outside Asia and North America.
Major Highlights of the Neglected Tropical Disease Treatment Market – Global Forecast 2019-2023
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the neglected tropical disease treatment market size during the next five years
- Precise estimation of the global neglected tropical disease treatment market share, size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the industry across Asia, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of the companies
We can help! Our analysts can customize the market research report to meet your requirements. Get in touch